Cargando…
A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial
INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has bee...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237711/ https://www.ncbi.nlm.nih.gov/pubmed/34194390 http://dx.doi.org/10.3389/fendo.2021.651273 |
_version_ | 1783714770410536960 |
---|---|
author | Tang, Yunhui Zhang, Yi Tang, Hanqing Che, Jiahui Feng, Hua Yao, Xiaoying Chen, Qi |
author_facet | Tang, Yunhui Zhang, Yi Tang, Hanqing Che, Jiahui Feng, Hua Yao, Xiaoying Chen, Qi |
author_sort | Tang, Yunhui |
collection | PubMed |
description | INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has been considered as an option of reducing intraoperative blood loss. However, UAE may be overused in clinical practice, especially in China. We present this protocol for a randomized clinical trial investigating the necessity of performing UAE for cesarean scar pregnancy, in combination with surgical suction curettage, taking into account the different subtypes of cesarean scar pregnancy. We recently developed a risk-scoring system (QRS) to estimate intraoperative blood loss, with 93.8% sensitivity and 6.3% false negative. Through this randomized clinical trial, we will retrospectively validate the QRS score on predicting intraoperative blood loss. METHODS AND ANALYSIS: We propose undertaking a randomized clinical trial sequentially recruiting 200 patients. All the patients will randomly receive ultrasound guided curettage with or without UAE. Data on the subtypes of cesarean scar pregnancy (Types 1 and II and III) detected by ultrasound will be collected before operation. The score on estimating intraoperative blood loss assessed by our recently developed quantitative risk-scoring system (QRS) will be collected before the operation. We will primarily compare the duration of the operation, intraoperative blood loss, and complications between the two groups. We will also retrospectively analyze the association of subtypes of cesarean scar pregnancy and the options of treatment and validate the QRS score. Outcomes of subsequent pregnancy within the 2-year follow-up will be secondary outcomes. TRIAL REGISTRATION NUMBER: [website], identifier ChiCTR2100041654. |
format | Online Article Text |
id | pubmed-8237711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82377112021-06-29 A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial Tang, Yunhui Zhang, Yi Tang, Hanqing Che, Jiahui Feng, Hua Yao, Xiaoying Chen, Qi Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Cesarean scar pregnancy affects 6% of all ectopic pregnancies in women with prior cesarean section, and there is currently no consensus on the optimal treatment. Options of surgical treatment have a risk of intraoperative blood loss; therefore, uterine artery embolization (UAE) has been considered as an option of reducing intraoperative blood loss. However, UAE may be overused in clinical practice, especially in China. We present this protocol for a randomized clinical trial investigating the necessity of performing UAE for cesarean scar pregnancy, in combination with surgical suction curettage, taking into account the different subtypes of cesarean scar pregnancy. We recently developed a risk-scoring system (QRS) to estimate intraoperative blood loss, with 93.8% sensitivity and 6.3% false negative. Through this randomized clinical trial, we will retrospectively validate the QRS score on predicting intraoperative blood loss. METHODS AND ANALYSIS: We propose undertaking a randomized clinical trial sequentially recruiting 200 patients. All the patients will randomly receive ultrasound guided curettage with or without UAE. Data on the subtypes of cesarean scar pregnancy (Types 1 and II and III) detected by ultrasound will be collected before operation. The score on estimating intraoperative blood loss assessed by our recently developed quantitative risk-scoring system (QRS) will be collected before the operation. We will primarily compare the duration of the operation, intraoperative blood loss, and complications between the two groups. We will also retrospectively analyze the association of subtypes of cesarean scar pregnancy and the options of treatment and validate the QRS score. Outcomes of subsequent pregnancy within the 2-year follow-up will be secondary outcomes. TRIAL REGISTRATION NUMBER: [website], identifier ChiCTR2100041654. Frontiers Media S.A. 2021-06-07 /pmc/articles/PMC8237711/ /pubmed/34194390 http://dx.doi.org/10.3389/fendo.2021.651273 Text en Copyright © 2021 Tang, Zhang, Tang, Che, Feng, Yao and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Tang, Yunhui Zhang, Yi Tang, Hanqing Che, Jiahui Feng, Hua Yao, Xiaoying Chen, Qi A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title | A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title_full | A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title_fullStr | A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title_full_unstemmed | A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title_short | A Comparison of Ultrasound Guided Curettage With and Without Uterine Artery Embolization on Controlling Intraoperative Blood Loss for a Cesarean Scar Pregnancy Treatment: Study Protocol for a Randomized Clinical Trial |
title_sort | comparison of ultrasound guided curettage with and without uterine artery embolization on controlling intraoperative blood loss for a cesarean scar pregnancy treatment: study protocol for a randomized clinical trial |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237711/ https://www.ncbi.nlm.nih.gov/pubmed/34194390 http://dx.doi.org/10.3389/fendo.2021.651273 |
work_keys_str_mv | AT tangyunhui acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT zhangyi acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT tanghanqing acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT chejiahui acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT fenghua acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT yaoxiaoying acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT chenqi acomparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT tangyunhui comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT zhangyi comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT tanghanqing comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT chejiahui comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT fenghua comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT yaoxiaoying comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial AT chenqi comparisonofultrasoundguidedcurettagewithandwithoututerinearteryembolizationoncontrollingintraoperativebloodlossforacesareanscarpregnancytreatmentstudyprotocolforarandomizedclinicaltrial |